U.K.-based Chiltern has rebranded as a completely integrated and unified CRO with services that are "Designed Around You.”
"We hear from our clients that Chiltern listens first in order to adapt to each unique relationship," said Dr. Jim Esinhart, Chiltern CEO. "Our refreshed theme is a direct response, as we steadily grow to meet the needs of our customers. Chiltern's culture embraces creativity and deep engagement through the application of therapeutic expertise within a flexible global platform that is distinctly 'Designed Around You.'"
The new Chiltern provides multinational therapeutic specialization in respiratory, anti-infectives/vaccines, ophthalmology and dermatology. In addition, the Chiltern Oncology division manages all phases of clinical development in a complex, constantly evolving cancer research environment. The Chiltern Source division provides tailored relationships for FSP, resourcing and staffing at a functional level for clinical, biometrics, medical and regulatory needs.